Mean residual survival as function of time.

(A) Median residual survival time after complete remission (CR) as a function of time to CR in patients with inv(16) or t(8;21). (B) Median residual survival time after CR or resistance as functions of the times to these events in patients with karyotypes other than inv(16) or t(8;21).